Global Pharmaceutical Logistics 2023

Now available to download

 

Global Pharmaceutical Logistics 2023 provides a detailed analysis of global pharmaceutical market sizing, broken down by region and select countries.

The report also provides an overview of the top trends in pharma and the developing pharmaceutical market, as well as an analysis of the top 10 pharmaceutical company revenues, with accompanying case studies.

Finally, the report examines at the top pharmaceutical logistics service providers.

The report contains data taken from our online data platform GSCI which contains much more detail about the pharmaceutical market, companies and trends.

This report contains:

  • Global pharmaceutical logistics market sizing and analysis for 2022-2027 - global and regional figures, and specific countries of particular interest.
  • An overview of top trends in the pharmaceutical market, including digitilization, online pharmacies, sustainability, divestment & acquisition, biologics and direct to patient.
  • An overview of pharmaceutical logistics service providers, including GXO, DSV, Bollore & Deutsche Post DHL Group.
  • Top 10 pharmaceutical company revenues 2018-2023.
  • Case studies of pharmaceutical companies.

This report contains:

  • Global pharmaceutical logistics market sizing and analysis for 2022-2027 - global and regional figures, and specific countries of particular interest.
  • An overview of top trends in the pharmaceutical market, including digitilization, online pharmacies, sustainability, divestment & acquisition, biologics and direct to patient.
  • An overview of pharmaceutical logistics service providers, including GXO, DSV, Bollore & Deutsche Post DHL Group.
  • Top 10 pharmaceutical company revenues 2018-2023.
  • Case studies of pharmaceutical companies.

Key findings:

  • The global pharmaceutical logistics market is estimated to grow at a 2022-2027 CAGR of 5.09%.
  • The market is still dominated on a regional level by North America.
  • Pharma supply chains are evolving due to new manufacturing techniques, the primacy of customized, specific treatments and a better understanding of the risks associated with global supply chains.
  • ‘Big pharma’ have turned their attention to ‘biologics’ or ‘biopharmaceuticals’ which have the potential for much higher profit margins.
  • Pharma companies are looking at how they can bring industry 4.0 technologies into their business strategy.
  • Many pharma organizations are divesting parts of themselves in order to fund acquisitions.

Key questions the report answers:

  • How did the market perform in 2022, and how will it perform in 2023 through to 2027?
  • How fast is each region growing?
  • What are the major factors affecting the global pharmaceutical logistics industry in 2023 and beyond?
  • What are the top Pharmaceutical trends for 2023 and beyond?
  • How is digitilization transforming the market?
  • What sustainability measures are leading Pharmaceutical logistics providers adopting?
  • Who are the Top 10 Pharmaceutical companies? And what are their revenues/inventory levels?
  • Who are the top Pharmaceutical logistics providers?

1 MARKET SIZING 6

1.1 GLOBAL MARKET SIZE 6

1.2 MARKET SIZE BY REGION 6

1.2.1 Growth Rates by Region: Overview 7

1.2.2 Market Forecasts and 2022-27 CAGR by Region: Overview 9

1.2.3 North America 9

1.2.3.1 Forecast and CAGR Rates 11

1.2.3.2 US 11

1.2.4 Europe 13

1.2.4.1 Europe 2020-27 CAGR Overview 14

1.2.4.2 Belgium 15

1.2.5.3 Switzerland 15

1.2.5.4 Germany 15

1.2.5.5 France 16

1.2.6 Asia Pacific 16

1.2.6.1 Asia Pacific 2022-2027 CAGR 17

1.2.6.2 India 18

1.2.6.3 China 19

1.2.6.4 Japan 22

1.2.7 South America 22

1.2.7.1 Brazil 23

1.2.7.2 Biosimilars 24

1.2.8 MENA 24

1.2.9 Russia, Caucasus and Central Asia 26

1.2.10 Sub-Saharan Africa 27

2 TOP TRENDS 29

2.1 DIGITALIZATION 29

2.2 DIVESTMENT AND ACQUISITION 30

2.3 SUSTAINABILITY 30

  

2.3.1 Transportation 30

2.4 BIOLOGICS 31

2.4.1 The Logistics of Biologics 32

2.4.2 Clinical Trials 34

2.4.3 Logistics Giants Leading the Way 35

2.5 DIRECT TO PATIENT 36

2.5.1 Growing need for ‘cool chain’ 37

2.5.2 Home Healthcare Market 38

2.6 ONLINE PHARMACIES 39

3 PHARMACEUTICAL COMPANIES 40

3.1 TOP 10 PHARMACEUTICAL COMPANIES BY REVENUE (€M) 40

3.2 CASE STUDIES 41

3.2.1 Johnson & Johnson 41

3.2.2 Merck 41

3.2.3 Pfizer 43

3.2.4 Roche 47

3.2.5 Novartis 51

4 PHARMACEUTICAL PROVIDERS 55

4.1 DSV 55

4.2 BOLLORE 55

4.3 CMA CGM GROUP 55

4.4 DEUTSCHE POST DHL GROUP 56

4.5 GXO 56

4.6 IMPERIAL LOGISTICS 57

4.7 KUEHNE + NAGEL 57

4.8 YUSEN 58

ABOUT TI 59

LICENCE AND COPYRIGHT 60

 

Julia Swales is Senior Editor for Ti Insight, Advisory Board Manager for the Foundation for Future Supply Chain and Director of Community Content at boom!

Julia was formerly Head of Publishing at a leading international independent business publisher in London, commissioning supply chain books for academic and professional markets. Now Julia has brought this knowledge and experience to a variety of market intelligence, research and content development roles, as well as being a co-founder of Sea Pen Books. 

6th June, 2023, Bath, UK, Ti Insight (Ti): The Ti Global Pharmaceutical Logistics Report 2023 provides:

  • Global pharmaceutical logistics market sizing and analysis
  • An overview of top trends in the pharmaceutical market
  • Top 10 pharmaceutical company revenues 2018-2023
  • Case studies of pharmaceutical companies
  • An overview of pharmaceutical logistics service providers

What are the major factors affecting the global pharmaceutical logistics industry in 2023 and beyond?

  • Pharmaceutical supply chain models are evolving, due to many factors including new manufacturing techniques and the primacy of customized, specific treatments at a ‘Batch Size 1’ patient level.
  • Changes are being forced upon the sector by a better understanding of the risks associated with global supply chains which have been pushed up the corporate agenda by the Covid-19 crisis and political tensions between the West and Russia and China.
  • ‘Big pharma’ companies have turned their attention to newer drugs, known as ‘biologics’ or ‘biopharmaceuticals’ which, due to their sophisticated and high value nature, have the potential for much higher profit margins than OTC drugs.
  • The global pharmaceutical market is still dominated on a regional level by North America, thanks to a strong US market with high levels of R&D spending and production.

This report is perfect for

  • Global manufacturers
  • Banks and financial institutions
  • Supply chain managers and directors
  • Logistics procurement managers
  • Marketing managers
  • Knowledge managers
  • Investors
  • All C-level executives

REPORT BROCHURE:

Enter your details below to download the report brochure.